Psychedelics Coursesby Blossom
ProfessionalHybridActive

integration therapy Courses

Browse courses focused on integration therapy, including clinician training in psychedelic harm reduction and integration. Listings in this skill area emphasize support for patients navigating psychedelic experiences in clinical and non-clinical settings.

Schedule

Next cohort: Dec 1, 2026

Enrollment

Price on request

Decision Summary

Best fit
Licensed clinicians and practitioners interested in psychedelic harm reduction, integration, and psychedelic-assisted psychotherapy.
Format
Hybrid
Time commitment
Not listed
Credential signal
Certificate listed

Upcoming Cohort

Start date: December 1, 2026

Course Overview

This course page groups listings related to integration therapy, with a focus on psychedelic harm reduction, patient support, and integration-oriented clinical practice. The available courses are aimed primarily at licensed clinicians and practitioners working with psychedelic-assisted care or related support roles. Courses in this category include professional certificate and specialty training options. Source details mention online delivery for some listings, with formats that may include guided externship, apprenticeship, consultation, and shadowing components depending on the course. Because this page is a skill directory rather than a single course, duration, level, and pricing vary by listing. Refer to each course page for the specific structure, eligibility, and enrollment details.

Who is this for?

Licensed clinicians and practitioners interested in psychedelic harm reduction, integration, and psychedelic-assisted psychotherapy.

Prerequisites

Varies by listing; some courses are designed for licensed clinicians, and some require prior KAP training.

About the Provider

Australian registered charity founded in 2019 that successfully campaigned for the Therapeutic Goods Administration (TGA) to reschedule psilocybin and MDMA in 2023 — making Australia the first country to formally approve these substances for clinical use. MMA trains clinicians through its Certificate in Psychedelic-Assisted Therapies (CPAT) program, funds clinical trials, and has supplied medicines and training to 100+ patients under the TGA Authorised Prescriber scheme.

View all Mind Medicine Australia courses

Course FAQ

Who is this course for?

Licensed clinicians and practitioners interested in psychedelic harm reduction, integration, and psychedelic-assisted psychotherapy.

Are there prerequisites?

Varies by listing; some courses are designed for licensed clinicians, and some require prior KAP training.

What is the format and time commitment?

Format: Hybrid.

How much does it cost?

This listing does not have a public price yet. Check the provider website for current tuition, fees, or application-based pricing.

Does it offer a certificate or CE/CME credit?

The listing includes a certificate signal. Confirm credential eligibility directly with the provider before enrolling.

When does the next cohort start?

The listed next cohort date is 2026-12-01.

Is this course currently available?

The current listing status is Active. Use the provider website for the latest enrollment status.

Related Courses

View all courses